Slingshot members are tracking this event:
Endo International(ENDP) will submit a supplemental request for labeling that will potentially add their abuse deterrent formulation claim to protected intellectual property
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
In parallel, and following our discussions with the FDA earlier this year, we expect to submit a supplemental request for labeling that will potentially add abuse-deterrent formulation claims. We expect to file that request in late 2015 or early 2016.
Slingshot Insights Explained
Aug 12, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Abuse Deterrent, Supplemental Request, Pain Management, Mystery Products